Annotations: 8V30

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D, E	Actin, gamma-enteric smooth muscle	binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding organic cyclic compound binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding organic cyclic compound binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding small molecule binding hydrolase activity catalytic activity	developmental process mesenchyme migration multicellular organismal process mesenchyme morphogenesis animal organ development mesenchyme development tissue development tissue morphogenesis anatomical structure morphogenesis tissue migration anatomical structure development animal organ morphogenesis regulation of cellular process cellular biosynthetic process developmental process mesenchyme migration multicellular organismal process mesenchyme morphogenesis animal organ development mesenchyme development tissue development tissue morphogenesis anatomical structure morphogenesis tissue migration anatomical structure development animal organ morphogenesis regulation of cellular process cellular biosynthetic process positive regulation of biological process positive regulation of cellular metabolic process positive regulation of macromolecule biosynthetic process positive regulation of metabolic process organic substance metabolic process positive regulation of biosynthetic process organic substance biosynthetic process positive regulation of macromolecule metabolic process positive regulation of cellular process regulation of biosynthetic process regulation of biological process cellular metabolic process biological regulation regulation of cellular metabolic process regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process regulation of cellular biosynthetic process regulation of gene expression biosynthetic process positive regulation of gene expression regulation of macromolecule biosynthetic process metabolic process cellular process macromolecule metabolic process regulation of metabolic process positive regulation of cellular biosynthetic process	cell projection cell leading edge cellular anatomical entity plasma membrane bounded cell projection lamellipodium extracellular region extracellular space blood microparticle intracellular organelle intracellular anatomical structure cytoskeleton organelle intracellular non-membrane-bounded organelle non-membrane-bounded organelle cell projection cell leading edge cellular anatomical entity plasma membrane bounded cell projection lamellipodium extracellular region extracellular space blood microparticle intracellular organelle intracellular anatomical structure cytoskeleton organelle intracellular non-membrane-bounded organelle non-membrane-bounded organelle extracellular exosome membrane-bounded organelle extracellular vesicle extracellular organelle vesicle extracellular membrane-bounded organelle cytoplasm cytosol cell periphery cell body myosin filament supramolecular fiber supramolecular polymer supramolecular complex actin-based cell projection filopodium
F, G, H, I, J	Phalloidin	-	-	-

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D, E	IPR020902	Actin/actin-like conserved site	Conserved Site
A, B, C, D, E	IPR004001	Actin, conserved site	Conserved Site
A, B, C, D, E	IPR043129	ATPase, nucleotide binding domain	Homologous Superfamily
A, B, C, D, E	IPR004000	Actin family	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D, E	Pharos: P63267	megacystis-microcolon-intestinal hypoperistalsis syndrome 1 malignant colon neoplasm visceral myopathy familial visceral myopathy pancreatic intraductal papillary-mucinous carcinoma polycystic ovary syndrome systemic lupus erythematosus visceral neuropathy, familial, autosomal dominant benign colon neoplasm chronic intestinal pseudoobstruction cystic fibrosis invasive ductal breast carcinoma medulloblastoma non-small cell lung carcinoma pancreatic intraductal papillary-mucinous neoplasm megacystis-microcolon-intestinal hypoperistalsis syndrome 1 malignant colon neoplasm visceral myopathy familial visceral myopathy pancreatic intraductal papillary-mucinous carcinoma polycystic ovary syndrome systemic lupus erythematosus visceral neuropathy, familial, autosomal dominant benign colon neoplasm chronic intestinal pseudoobstruction cystic fibrosis invasive ductal breast carcinoma medulloblastoma non-small cell lung carcinoma pancreatic intraductal papillary-mucinous neoplasm psoriasis breast cancer colonic neoplasm endometriosis lung adenocarcinoma malignant ependymoma ovarian cancer pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia Sjogren syndrome Visceral Myopathy, Familial breast carcinoma congenital anomaly of kidney and urinary tract lung carcinoma malignant mesothelioma neuronal intestinal dysplasia

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B, C, D, E	HIC	Parent Component: HIS RESID: AA0317 PSI-MOD : 1'-methyl-L-histidine MOD:00322
F, G, H, I, J	DTH	RESID: AA0317 , AA0199 PSI-MOD : 1'-methyl-L-histidine MOD:00322 , D-allo-threonine MOD:00863
F, G, H, I, J	EEP	RESID: AA0317 , AA0199
F, G, H, I, J	HYP	Parent Component: PRO RESID: AA0317 , AA0199 , AA0030 PSI-MOD : 1'-methyl-L-histidine MOD:00322 , D-allo-threonine MOD:00863 , 4-hydroxy-L-proline MOD:00039

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.